Last 12 months
Inside the activity.
8 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 2 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 4 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2024 Filed Dec 19, 2024 02:19 UTC |
Paterson WayneDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 41,222 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0001104659-24-129873 · tm2431370-5_4seq1.xml · derivative · entry 5 Paterson Wayne · CIK 0001640666 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,222 Underlying: Common Stock · 41,222 shares Expires 2027-06-13 F2 · derivative.exercise_price: Options are issued in AUD. Exercise prices have been translated into USD using the December 15, 2024 exchange rate, which was approximately A$1.00 to $0.64. F3 · kind: Legacy awards originally issued by ATL that were assumed by the Issuer pursuant to a scheme of arrangement between ATL and its optionholders under Part 5.1 of the Corporations Act, effective on the Effective Date. F7 · derivative.exercise_date: The option vests in three equal annual installments beginning on December 31, 2022, subject to the Reporting Person's continued service. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:19 UTC |
Paterson WayneDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 233,000 | $0.00 Strike: $7.13 | $0.00 |
DisclosureSEC source: 0001104659-24-129873 · tm2431370-5_4seq1.xml · derivative · entry 4 Paterson Wayne · CIK 0001640666 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,000 Underlying: Common Stock · 233,000 shares Expires 2025-03-20 F2 · derivative.exercise_price: Options are issued in AUD. Exercise prices have been translated into USD using the December 15, 2024 exchange rate, which was approximately A$1.00 to $0.64. F3 · kind: Legacy awards originally issued by ATL that were assumed by the Issuer pursuant to a scheme of arrangement between ATL and its optionholders under Part 5.1 of the Corporations Act, effective on the Effective Date. F6 · derivative.exercise_date: The option vested in two equal installments on February 8, 2022 and June 24, 2022. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:19 UTC |
Paterson WayneDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 31,890 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001104659-24-129873 · tm2431370-5_4seq1.xml · derivative · entry 3 Paterson Wayne · CIK 0001640666 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,890 Underlying: Common Stock · 31,890 shares Expires 2029-05-15 F2 · derivative.exercise_price: Options are issued in AUD. Exercise prices have been translated into USD using the December 15, 2024 exchange rate, which was approximately A$1.00 to $0.64. F3 · kind: Legacy awards originally issued by ATL that were assumed by the Issuer pursuant to a scheme of arrangement between ATL and its optionholders under Part 5.1 of the Corporations Act, effective on the Effective Date. F5 · derivative.exercise_date: The option vested in three equal annual installments beginning on December 31, 2019. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:19 UTC |
Paterson WayneDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 14,358 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001104659-24-129873 · tm2431370-5_4seq1.xml · derivative · entry 2 Paterson Wayne · CIK 0001640666 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,358 Underlying: Common Stock · 14,358 shares Expires 2027-12-31 F2 · derivative.exercise_price: Options are issued in AUD. Exercise prices have been translated into USD using the December 15, 2024 exchange rate, which was approximately A$1.00 to $0.64. F3 · kind: Legacy awards originally issued by ATL that were assumed by the Issuer pursuant to a scheme of arrangement between ATL and its optionholders under Part 5.1 of the Corporations Act, effective on the Effective Date. F4 · derivative.exercise_date: The option vested in three equal annual installments beginning on December 31, 2018. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:19 UTC |
Paterson WayneDirector · Chief Executive Officer
|
GrantCommon Stock | 20,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-129873 · tm2431370-5_4seq1.xml · nonDerivative · entry 1 Paterson Wayne · CIK 0001640666 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,334 F1 · kind: Received in exchange for an equivalent number of ordinary shares of Anteris Technologies Ltd ("ATL") in connection with a series of reorganization transactions pursuant to which the Issuer received all of the issued and outstanding shares of ATL pursuant to a scheme of arrangement (the "Scheme") under Australian law between ATL and its shareholders under Part 5.1 of the Australian Corporations Act 2001 (Cth) (the "Corporations Act"). On December 16, 2024, the effective date of the Scheme and the closing of the Issuer's U.S. initial public offering (the "Effective Date"), the closing price of the Issuer's common stock was $5.50 per share. F1 · price: Received in exchange for an equivalent number of ordinary shares of Anteris Technologies Ltd ("ATL") in connection with a series of reorganization transactions pursuant to which the Issuer received all of the issued and outstanding shares of ATL pursuant to a scheme of arrangement (the "Scheme") under Australian law between ATL and its shareholders under Part 5.1 of the Australian Corporations Act 2001 (Cth) (the "Corporations Act"). On December 16, 2024, the effective date of the Scheme and the closing of the Issuer's U.S. initial public offering (the "Effective Date"), the closing price of the Issuer's common stock was $5.50 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.